Header Logo
Newsletter Podcast
Log In
← Back to all posts

Lasting Relief, Better Outcomes—Plus What PRP Docs Are Doing Differently

Apr 29, 2025
Connect

Highlights

  • Today’s Research Article: Your go-to treatment just got outperformed—see why PRP is leading in joint relief.

  • Questions from the Field: Even if they’re under 65, it’s better to have the ABN signed—every time.

  • Let’s Get Down to Business: Educate, personalize, and document—keys to building a thriving PRP practice.

  • Come Join Us: Train smarter, connect deeper—your next breakthrough starts at a live event.

If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.


Today’s Research Article

Platelet-Rich Plasma versus Corticosteroid Intra-Articular Injections for the Treatment of Trapeziometacarpal Arthritis: A Prospective Randomized Controlled Clinical Trial

Michael-Alexander Malahias, Leonidas Roumeliotis, Vasileios S. Nikolaou, Efstathios Chronopoulos, Ioannis Sourlas, and Georgios C. Babis

Read the full article here.

Summary:

This prospective randomized controlled trial by Malahias et al. compared intra-articular platelet-rich plasma (IA-PRP) injections with corticosteroid injections for treating early to moderate trapeziometacarpal (thumb base) arthritis. Over 12 months, patients receiving IA-PRP experienced significantly better outcomes in pain relief (VAS score), hand function (Q-DASH score), and satisfaction than those treated with corticosteroids. While both treatments showed improvement at 3 months, only the PRP group maintained and improved these benefits at 12 months, with 62.5% of PRP patients reporting mild pain vs. just 12.5% in the steroid group.

The study also demonstrated that patient satisfaction with PRP rose over time, reaching 69% at 12 months compared to only 12.5% in the steroid group. This sustained improvement is attributed to PRP’s biological effects, including anti-inflammatory properties and stimulation of cartilage repair. Given its longer-lasting relief and functional improvement, IA-PRP offers a superior non-surgical option for managing mild to moderate thumb arthritis compared to the short-lived effects of corticosteroids.

Doctor-to-Patient Talking Points for Choosing IA-PRP Over Steroids (with Evidence)

Subscribe to keep reading this post

Subscribe

Already have an account? Log in

Loading...
Real Results with PRP, Staff Scripts That Work, and Events You’ll Love
Highlights Today’s Research Article: PRP wins the long game — outperforms kinesiotaping for chronic heel pain with lasting relief and tissue regeneration. Questions from the Field: Can you combine PRP and protein concentrate for osteoarthritis? Absolutely — and here’s why it works. Let’s Get Down to Business: Your front desk is your secret salesforce — train them to sell PRP with empathy, not...
PRP Wins Big, Raise Your Rates, Master Your Marketing
Highlights Today’s Research Article: PRP delivers twice the healing at six months compared to steroids — and helps patients avoid surgery. Questions from the Field: When your results are better, your price should be too — charge for the quality and outcomes you deliver. Let’s Get Down to Business: If patients can’t find you online, they’ll never book — make digital marketing your best cl...
The Science, Strategy, and Events You Can’t Miss in Regenerative Medicine
Highlights Today’s Research Article: PRP Outperforms Physical Therapy in Tennis Elbow—With Healing You Can See on MRI. Questions from the Field: Bone Marrow vs. Adipose for Knees? Use the Right Tool for the Right Target. Let’s Get Down to Business: Stop Selling PRP Like a Backup Plan—Position It as the Smart, First-Line Solution. Come Join Us: Sharpen Your Skills and Expand Your Networ...

The OBX Brief

Your guide to Orthobiologics Literature
Footer Logo
Newsletter Podcast
© 2025 Kajabi
Powered by Kajabi

Join Our Free Trial

Get started today before this once in a lifetime opportunity expires.